These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 468977)

  • 1. Calcitonin in nonthyroidal cancer.
    Schwartz KE; Wolfsen AR; Forster B; Odell WD
    J Clin Endocrinol Metab; 1979 Sep; 49(3):438-44. PubMed ID: 468977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The differential diagnosis of hypercalcitoninism].
    Dambacher MA; Born W; Heitz PU; Olah AJ; Tobler PH; Fischer JA
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1897-901. PubMed ID: 7330642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin in breast and lung cancer.
    Hillyard CJ; Coombes RC; Greenberg PB; Galante LS; MacIntyre I
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):1-8. PubMed ID: 942890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.
    Ghillani PP; Motté P; Troalen F; Jullienne A; Gardet P; Le Chevalier T; Rougier P; Schlumberger M; Bohuon C; Bellet D
    Cancer Res; 1989 Dec; 49(23):6845-51. PubMed ID: 2555054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation.
    Silk M
    Cancer; 1967 Dec; 20(12):2088-9. PubMed ID: 5624179
    [No Abstract]   [Full Text] [Related]  

  • 6. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer.
    Nielsen VG; Matika RW; Ley ML; Waer AL; Gharagozloo F; Kim S; Nfonsam VN; Ong ES; Jie T; Warneke JA; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):248-53. PubMed ID: 24674880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
    McLeod MK; Vinik AI
    Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects.
    Karanikas G; Moameni A; Poetzi C; Zettinig G; Kaserer K; Bieglmayer C; Niederle B; Dudczak R; Pirich C
    J Clin Endocrinol Metab; 2004 Feb; 89(2):515-9. PubMed ID: 14764755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma calcitonin as a marker of disease activity in patients with small cell carcinoma of the lung.
    Wallach SR; Royston I; Taetle R; Wohl H; Deftos LJ
    J Clin Endocrinol Metab; 1981 Sep; 53(3):602-6. PubMed ID: 6267098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic production of lipotropin by cancer.
    Odell WD; Wolfsen AR; Bachelot I; Hirose FM
    Am J Med; 1979 Apr; 66(4):631-8. PubMed ID: 433967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
    Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
    Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monomeric plasmatic calcitonin and hypercalcemia in lung cancer patients].
    Coifman R; Weforte RV; Kasamatsu TS; Fukusima L; Santoro I; Jamnik S; Vieira JG; Castro ML
    Rev Assoc Med Bras (1992); 1997; 43(2):105-8. PubMed ID: 9336044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcitonin. III. Use of serum calcitonin as a tumor marker in breast and pulmonary neoplasms].
    Gadesberg CC; Nielsen HE; Olsen KJ; Hansen HH
    Ugeskr Laeger; 1979 Oct; 141(40):2744-6. PubMed ID: 531963
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunologic analysis of changes in the level of beta-2-microglobulin in cancer].
    Zubovskiĭ LG; Polevaia EB; Kirsanov AG; Shiriaev SV
    Med Radiol (Mosk); 1982 Aug; 27(8):50-3. PubMed ID: 6182439
    [No Abstract]   [Full Text] [Related]  

  • 17. A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.
    Body JJ; Dumon JC; Sculier JP; Dabouis G; Lacroix H; Libert P; Richez M; Bureau G; Mommen P; Raymakers N
    Henry Ford Hosp Med J; 1989; 37(3-4):190-3. PubMed ID: 2639133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Kumar SS; Reddy H; Semenya KA; Hardy RE
    J Med; 1987; 18(5-6):323-32. PubMed ID: 3505259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin as a marker for bronchogenic cancer: a prospective study.
    Silva OL; Broder LE; Doppman JL; Snider RH; Moore CF; Cohen MH; Becker KL
    Cancer; 1979 Aug; 44(2):680-4. PubMed ID: 476577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.